What Is the Difference Between the Hemp and Marijuana Industries?

The distinction between hemp and marijuana is legally defined but has created two very different industries with distinct regulatory frameworks, business models, and investment characteristics. Understanding this distinction is essential for cannabis investors navigating the complex legal landscape.

The 2018 Farm Bill established the legal definition: hemp is cannabis with less than 0.3% delta-9 THC by dry weight, while marijuana is any cannabis that exceeds this threshold. This seemingly arbitrary line creates profoundly different legal environments. Hemp is federally legal, can be transported across state lines, and businesses can access traditional banking, major exchange listings, and standard business services. Marijuana remains a Schedule I controlled substance, confined to state-legal markets without interstate commerce, and subject to the crippling Section 280E tax burden.

The hemp industry encompasses several distinct segments. CBD products (oils, tinctures, edibles, topicals) represent the largest hemp-derived market, valued at approximately $5-6 billion annually. However, this market has faced challenges including FDA regulatory uncertainty, product quality inconsistency, market saturation, and price compression. Hemp fiber is used in textiles, building materials (hempcrete), and automotive components. Hemp grain and seed provide nutritional products including hemp hearts, hemp protein, and hemp seed oil. The hemp industry also produces animal feed, bioplastics, and other industrial applications.

A significant trend blurring the hemp-marijuana distinction is the emergence of hemp-derived cannabinoids like delta-8 THC, THC-O, and HHC. These compounds are chemically converted from hemp-derived CBD and can produce psychoactive effects similar to traditional marijuana, yet technically fall under the hemp legal umbrella because they are derived from plants with less than 0.3% delta-9 THC. This loophole has created a multi-billion dollar market that has drawn regulatory scrutiny from both state and federal authorities, with many states now banning or restricting these products.

For investors, the hemp and marijuana industries present different risk-reward profiles. Hemp companies — like Charlotte's Web (CWBHF) and CV Sciences (CVSI) — can list on major exchanges and access traditional capital markets but operate in a highly competitive, lower-margin environment without the supply constraints that protect marijuana operator pricing. Marijuana companies face higher regulatory risk and operational costs but benefit from limited competition, higher margins, and the potential for massive value unlocking through federal reform. Some companies, like Tilray, operate in both spaces, providing diversified exposure across the cannabis continuum.